[HTML][HTML] Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma

S Hua, X Gu, H **, X Zhang, Q Liu, J Yang - Biomedicine & …, 2024 - Elsevier
Cholangiocarcinoma (CCA) is becoming more common and deadly worldwide. Tumor-
infiltrating T cell subtypes make distinct contributions to the immune system; collectively, they …

Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies

M Zhang, H Qin, Y Wu, Q Gao - Cancer Biology & Medicine, 2024 - cancerbiomed.org
Neutrophils, which originate from the bone marrow and are characterized by a segmented
nucleus and a brief lifespan, have a crucial role in the body's defense against infections and …

Neutrophil profiling illuminates anti-tumor antigen-presenting potency

Y Wu, J Ma, X Yang, F Nan, T Zhang, S Ji, D Rao… - Cell, 2024 - cell.com
Neutrophils, the most abundant and efficient defenders against pathogens, exert opposing
functions across cancer types. However, given their short half-life, it remains challenging to …

[HTML][HTML] KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)

R Rosell, J Codony-Servat, J González… - Critical reviews in …, 2024 - Elsevier
Abstract KRAS G12C mutations in non-small cell lung cancer (NSCLC) partially respond to
KRAS G12C covalent inhibitors. However, early adaptive resistance occurs due to rewiring …

Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment

Z Fang, J Jiang, X Zheng - Life Sciences, 2023 - Elsevier
The interleukin-1 receptor antagonist (IL-1Ra) is an anti-inflammatory cytokine and a
naturally occurring antagonist of the IL-1 receptor. It effectively counteracts the IL-1 signaling …

Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing

Z Wang, L Gao, Z Jia, L Liu, A Gu, Z Liu, Q Zhu… - … and Targeted Therapy, 2025 - nature.com
Aberrant RNA alternative splicing in cancer generates varied novel isoforms and protein
variants that facilitate cancer progression. Here, we employed the advanced long-read full …

Targeting RNA splicing modulation: new perspectives for anticancer strategy?

X Lv, X Sun, Y Gao, X Song, X Hu, L Gong… - Journal of Experimental …, 2025 - Springer
The excision of introns from pre-mRNA is a crucial process in the expression of the majority
of genes. Alternative splicing allows a single gene to generate diverse mRNA and protein …

Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers

H Liao, X Chen, H Wang, Y Lin, L Chen, K Yuan… - Cancer Research, 2024 - AACR
Intrahepatic cholangiocarcinoma (iCCA) is the second most prevalent primary liver cancer.
Although the genetic characterization of iCCA has led to targeted therapies for treating …

[HTML][HTML] Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers

A Strati, C Adamopoulos, I Kotsantis, A Psyrri… - International Journal of …, 2025 - mdpi.com
The PD1/PD-L1 axis plays an important immunosuppressive role during the T-cell-mediated
immune response, which is essential for the physiological homeostasis of the immune …

Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach

L Hai, XY Bai, X Luo, SW Liu, ZM Ma, LN Ma… - Frontiers in …, 2024 - frontiersin.org
Background The prognostic value and immune significance of T-cell proliferation regulators
(TCRs) in hepatocellular carcinoma (HCC) have not been previously reported. This study …